The Journal of Antimicrobial Chemotherapy (JAC) is a leading international forum dedicated to the dissemination of high-quality research on antimicrobial agents, their use in therapy, and the mechanisms of resistance. It serves as a vital resource for researchers, clinicians, and policymakers in the fight against infectious diseases.
JAC covers a wide range of topics, from the discovery and development of new antimicrobial drugs to the evaluation of antimicrobial stewardship programs and the surveillance of antimicrobial resistance. It explores bacterial, viral, fungal, and parasitic infections, as well as the pharmacology, toxicology, and clinical efficacy of antimicrobial agents. Indexed in databases such as MEDLINE, Scopus, and Web of Science, it provides access to impactful research and up-to-date information.
By promoting evidence-based practice and interdisciplinary collaboration, the Journal of Antimicrobial Chemotherapy aims to improve outcomes for patients with infectious diseases and to combat the growing threat of antimicrobial resistance. Submit your research to contribute to this highly respected journal and help shape the future of antimicrobial therapy.